<DOC>
	<DOCNO>NCT02974283</DOCNO>
	<brief_summary>The purpose study find serum marker evaluation blood brain barrier damage base animal experiment investigate effect NBO（Normobaric hyperoxia）on blood brain barrier acute ischemic stroke patient receive r-tPA thrombolytic therapy .</brief_summary>
	<brief_title>Protective Effects Normobaric Hyperoxia Blood Brain Barrier Patients With Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hyperoxia</mesh_term>
	<mesh_term>Fibrinolytic Agents</mesh_term>
	<criteria>1 . Male female age 18 85 ; 2 . Acute ischemic stroke ; 3 . National Institutes Health Stroke Scale ( NIHSS ) score 425 4. mRS score le 1 onset stroke symptom ; 5 . Onset stroke symptom within 4.5h initiation intravenous rtPA thrombolytic therapy ; 6 . Informed consent obtain 1 . Stroke serious head trauma within previous 3 month 2 . Major surgery severe trauma precede 3 month 3 . Intracranial hemorrhage 4 . Systolic pressure great 185 mm Hg diastolic pressure great 110 mm Hg , aggressive treatment intravenous medication ) necessary reduce blood pressure limit 5 . Symptoms rapidly improve 6 . Symptoms suggestive subarachnoid hemorrhage , even CT scan normal 7 . Gastrointestinal hemorrhage urinary tract hemorrhage within previous 21 day 8 . Arterial puncture noncompressible site within previous 7 day 9 . Seizure onset stroke 10 . Platelet count le 100,000 per cubic millimeter 11 . Received heparin within 48 hour precede onset stroke elevate partialthromboplastin time 12 . Received oral anticoagulation therapy precede onset stroke INR great 1.7 prothrombin time great 15 second 13 . CT show multiple infarction ( low density area great 1/3 cerebral hemisphere ) 14. severe hepatic renal dysfunction 15. active chronic obstructive pulmonary disease acute respiratory distress syndrome ; 16 . &gt; 3 L/min oxygen require maintain peripheral arterial oxygen saturation ( SaO2 ) ﹥95 % per current stroke management guideline ; 17 medically unstable ; 18. inability obtain informed consent . 19 . Life expectancy &lt; 1 year 20 . Pregnant breastfeed woman 21 . Unwilling follow poor compliance treatment 22 . Patients enrol enrolled clinical trial within 3 month prior clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Normobaric hyperoxia</keyword>
	<keyword>r-tPA thrombolytic therapy</keyword>
</DOC>